IP Verse

Neuefeind, Regina Analysis

LAW FIRM ANALYSIS

Latest European patent oppositions filed by Neuefeind, Regina

Patent:
EP3241908
Title:
Method For Regulating Glycosylation Of Recombinant Glycoprotein
Applicant:
LG CHEM, LTD.
Opposition Date:
2021-05-04
Patent:
EP2061803
Title:
Process For The Purification Of Fc-Containing Proteins
Applicant:
ARES TRADING S.A.
Opposition Date:
2020-05-14
Patent:
EP2766040
Title:
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab
Applicant:
F.HOFFMANN-LA ROCHE AG
Opposition Date:
2020-02-17
Patent:
EP2952202
Title:
Gip-Based Mixed Agonists For Treatment Of Metabolic Disorders And Obesity
Applicant:
INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION
Opposition Date:
2018-07-17
Patent:
EP2906683
Title:
Mammalian Cell Culture Processes For Protein Production
Applicant:
BRISTOL-MYERS SQUIBB COMPANY
Opposition Date:
2018-02-28
Patent:
EP2154244
Title:
Cell Culture Method Using Amino Acid-Enriched Medium
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Opposition Date:
2018-01-12

Top clients of Neuefeind, Regina filing patent oppositions

Company:
NEUEFEIND, REGINA
Count:
4
Company:
DR. REDDY'S LABORATORIES LIMITED
Count:
1
Company:
MAIWALD GMBH
Count:
1